The use of high-sensitivity assays for C-reactive protein in clinical practice.
about
CRP in cardiovascular diseasePioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective studyGender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.Changes in C-reactive protein during weight loss and the association with changes in anthropometric variables in men and women: LIFE Study.C-Reactive Protein: How Has JUPITER Impacted Clinical Practice?Modulatory Effect of Inflammation on Blood Pressure Reduction via Therapeutic Lifestyle Change.Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.Association of High Sensitivity C-Reactive Protein Concentrations and Metabolic Syndrome among Thai Adults.Java project on periodontal diseases: effect of vitamin C/calcium threonate/citrus flavonoids supplementation on periodontal pathogens, CRP and HbA1c.The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaquesHigh-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults.Should C-reactive protein be a target of therapy?Impact of ezetimibe on atherosclerosis: is the jury still out?Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC StudyPrimary and secondary prevention of cardiovascular diseases: a practical evidence-based approachImpact of aerobic exercise on levels of IL-4 and IL-10: results from two randomized intervention trials.The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis.Study of High Sensitive C-Reactive Protein (HS-CRP) After Cardiac Rehabilitation Program in Patients Undergoing Isolated CABG.Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis.Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.Clinical relevance for lowering C-reactive protein with statins.High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.Association between C-reactive protein and physical performance in older populations: results from the International Mobility in Aging Study (IMIAS).Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis.Survival Advantage Mechanism: Inflammation as a Mediator of Positive Self-Perceptions of Aging on Longevity.Dietary intake and cardiometabolic biomarkers in relation to insulin resistance and hypertension in a middle-aged and elderly population in Beijing, China.Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan.Oxidative stress and insulin resistance in policemen working shifts.
P2860
Q28268282-F5511A44-0FC3-4582-B388-4A8C97342821Q33937311-C0DE2024-89FB-4019-9B05-44D94AA1790FQ34027430-1C34B0E5-EB18-4EC2-83E2-E2E65B5759EAQ34048554-0A91D24E-5458-444E-8308-793500477FDFQ34420387-FFDC6002-B2C9-4294-941F-8E38D9A85D53Q34440730-D1E7CADD-5DD0-4479-B74A-9A6E6752E8ABQ34986430-F6790F8D-880D-4AA2-A75E-B213E4735150Q34986455-BBA51386-A8D2-4D9D-AB7A-9652527C67C8Q35088117-EB169FFA-2203-4B64-822A-3FF7381D0F79Q35665122-E0AFF15D-F8CE-4C29-A594-324BC4AAC256Q35835532-E9DBA7AA-ABCE-463C-A700-03C7960DFD8CQ36334087-AE26E67B-BB00-4A8A-8C79-4C05026FD79AQ36344725-701ED4AD-48FE-4A13-AEBE-839A237FE345Q36783729-B0379C21-A069-4447-9698-430A41AF2D64Q37151389-15000D9D-9DD2-4276-BCEA-6E02CDFE981AQ37197634-5587EF9D-B660-488C-A2F0-8D2B0FFDA903Q37285574-4EDA04B7-A9E8-4F64-BDC1-9D5D110992DDQ37321111-8EF6A744-4DFF-46F1-973A-3949049ED553Q37505886-0F1797CA-F056-4EFD-A35A-6B8D2F5E4E1FQ37600685-3B159C7A-8369-498E-8371-EA5FEF7A7B74Q37608077-A8C85056-E183-483F-ABD4-D0C61D64D63BQ37609683-36BE0C33-1FD0-4B51-B7CC-F4473A0C1434Q37825592-C6C4B41A-087A-4EA0-AAE1-F36AE2E4401EQ38880500-43EEA243-F448-453C-8786-36527E828B51Q38913955-871E95D9-E7B8-4D98-9249-800511829486Q39354235-1DF0743C-5E82-4A32-9057-AB0C456DDF57Q40046981-153A6BEC-C209-4991-99C1-D232DD889ED5Q44792514-A90F51BE-582B-49DB-9CD0-75B09F240040Q50221747-07231377-A872-4522-9432-927A74714C44Q51267744-146BA4C4-81A7-43D5-94DA-A8AD828EDA34Q53793103-861C998B-4CB8-4DF7-A6D0-1725E7EF6435Q53829403-B8F9FA00-C820-434F-9A81-8DB584AD9B4A
P2860
The use of high-sensitivity assays for C-reactive protein in clinical practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@en
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@nl
type
label
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@en
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@nl
prefLabel
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@en
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@nl
P2093
P2860
P356
P1476
The use of high-sensitivity assays for C-reactive protein in clinical practice.
@en
P2093
Brian G Kral
Catherine Y Campbell
James T Willerson
Kiran Musunuru
Michael H Davidson
Milind Y Desai
Richard A Lange
Roger S Blumenthal
Samia Mora
Ty J Gluckman
P2860
P304
P356
10.1038/NCPCARDIO1322
P577
2008-08-19T00:00:00Z